Submitted by Anonymous (not verified) on 6 February 2026 - 14:45
Human medicines European public assessment report (EPAR): Alymsys, bevacizumab, Date of authorisation: 26/03/2021, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Alymsys, bevacizumab, Date of authorisation: 26/03/2021, Revision: 12, Status: Authorised